Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
Biogen stock (symbol: BIIB) underwent a total of 2 stock splits.The most recent stock split occurred on January 18th, 2001.One BIIB share bought prior to December 21st, 1999 would equal to 6 BIIB shares today.